US Patent Issued to SHANGHAI HANSOH BIOMEDICAL, JIANGSU HANSOH PHARMACEUTICAL GROUP on Dec. 16 for "Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,366, issued on Dec. 16, was assigned to SHANGHAI HANSOH BIOMEDICAL Co. LTD. (Shanghai) and JIANGSU HANSOH PHARMACEUTICAL GROUP Co. LTD. (Jiangsu, China).

"Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereof" was invented by Jiaqiang Dong (Shanghai), Xinxian Deng (Shanghai), Wensheng Yu (Shanghai), Fangfang Jin (Shanghai) and Zhen Gong (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A nitrogen-containing heterocyclic derivative inhibitor, a preparation method therefor and the use thereof. Specifically disclosed are a compound as represented by general formula (I), a preparation method therefor, ...